Journals
Publish with us
Publishing partnerships
About us
Blog
Mediators of Inflammation
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Mediators of Inflammation
/
2016
/
Article
/
Tab 1
/
Review Article
miRNAs Participate in MS Pathological Processes and Its Therapeutic Response
Table 1
MiRNA biomarkers of therapeutic response in multiple sclerosis (MS).
Drug treatment
Increased miRNA
Decreased miRNA
NatalizumAb
miR-18a, 20b, 29a, 103
miR-326, 17
INF-
β
miR-26-5p, 16-5p, 342-5p, 346, 518b, 760, let-7a-5p, 7b-5p
miR-27a-5p, 29a-3p, 29b-1-5p, 29c-3p, -95, 149-5p, 181c-3p, 193a-3p, -193-5p, 423-5p, 532-5p, 708-5p, 874
GA
miR-146a, miR-142-3p
GSK3
β
inhibitors
miR-98 and let-7g